Cannabinoid receptor 1 and cannabinoid receptor 2 are recognized to play a protective role in IBD, namely, by functioning to control the inflammatory status and are normally present during weaning and starvation [28]. This evidence concerns the gene CNR2 and irritable bowel syndrome.